PN
Polynovo
PNV.AX·ASXMelbourne AUFounded 2014200 employees
Small CapbiotechPublicDermatology
Platform: NovoSorb BTM
Market Cap
$0.8B
All Drugs
2
Clinical Trials
5
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (PNV.AX)
Loading PNV.AX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Doxacilimab | PNV-266 | Preclinical | 2 | CD19 | FTD | ||
| Fixacagene | PNV-5602 | Approved | 3 | GLP-1R | Endometrial CaMM |
SEC Filings & Financial Documents
SEC filings are not available for ASX-listed companies.
Polynovo trades on ASX (AU). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)